Full text

Turn on search term navigation

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

A laser technology for creating nanocomposites from alternating layers of albumin/collagen proteins with two types of single-walled carbon nanotubes (SWCNT) at concentrations of 0.001 and 0.01 wt.% was proposed. For this purpose, a setup with a diode laser (810 nm) and feedback system for controlling the temperature of the area affected by the radiation was developed. Raman spectroscopy was used to determine a decrease in the defectiveness of SWCNT with an increase in their concentration in the nanocomposite due to the formation of branched 3D networks with covalent bonds between nanotubes. It was revealed that adhesion of proteins to branched 3D networks from SWCNT occurred. The specific electrical conductivity of nanocomposites based on large SWCNT nanotubes was 3.2 and 4.3 S/m compared to that for nanocomposites based on small SWCNT with the same concentrations—1.1 and 1.8 S/m. An increase in the concentration and size of nanotubes provides higher porosity of nanocomposites. For small SWCNT-based nanocomposites, a significant number of mesopores up to 50 nm in size and the largest specific surface area and specific pore volume were found. Nanocomposites with small SWCNT (0.001 wt.%) provided the best cardiac fibroblast viability. Such technology can be potentially used to create bioelectronic components or scaffolds for heart tissue engineering.

Details

Title
Laser Technology for the Formation of Bioelectronic Nanocomposites Based on Single-Walled Carbon Nanotubes and Proteins with Different Structures, Electrical Conductivity and Biocompatibility
Author
Alexander Yu Gerasimenko 1   VIAFID ORCID Logo  ; Kurilova, Uliana E 1 ; Suetina, Irina A 2 ; Mezentseva, Marina V 2 ; Zubko, Aleksandr V 3 ; Sekacheva, Marina I 4 ; Glukhova, Olga E 5   VIAFID ORCID Logo 

 Institute of Biomedical Systems, National Research University of Electronic Technology MIET, Shokin Square 1, 124498 Zelenograd, Russia; [email protected]; Institute for Bionic Technologies and Engineering, I.M. Sechenov First Moscow State Medical University, Bolshaya Pirogovskaya Street 2-4, 119991 Moscow, Russia; [email protected] 
 Ivanovsky Institute of Virology, National Research Center for Epidemiology and Microbiology, Gamaleya Street 18, 123098 Moscow, Russia; [email protected] (I.A.S.); [email protected] (M.V.M.) 
 Cell Technology and Molecular Genetic Research Group, A.N. Bakulev National Medical Research Center of Cardiovascular Surgery, Roublyevskoe Shosse 135, 121552 Moscow, Russia; [email protected] 
 Institute of Personalized Oncology, I.M. Sechenov First Moscow State Medical University, Bolshaya Pirogovskaya Street 2-4, 119991 Moscow, Russia; [email protected] 
 Institute for Bionic Technologies and Engineering, I.M. Sechenov First Moscow State Medical University, Bolshaya Pirogovskaya Street 2-4, 119991 Moscow, Russia; [email protected]; Department of Physics, Saratov State University, Astrakhanskaya Street 83, 410012 Saratov, Russia 
First page
8036
Publication year
2021
Publication date
2021
Publisher
MDPI AG
e-ISSN
20763417
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2570598344
Copyright
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.